CellaVision AB: Nomination Committee proposes re-election of Chairman and members to the Board of Directors
(Thomson Reuters ONE) -
This information was released for public disclosure on January 27, 2017 at
08.20 am CET.
CellaVision AB (public) today announced that its Nomination Committee
proposes re-election of Sören Mellstig as Chairman of the Board and re-election
of Christer Fåhraeus, Åsa Hedin, Roger Johanson, Torbjörn Kronander, Anna Malm
Bernsten and Niklas Prager as Directors of the Board.
The Nomination Committee consists of the four largest shareholders represented
by Nominatoion Committee Chairman Christer Fåhraeus (appointed by Christer
Fåhraeus and companies), Bo Lundgren (appointed by Swedbank Robur Funds),
Caroline Sjösten (appointed by Skandia Liv), Joel Eklund (appointed by Eklund &
Peterson AB) and the Chairman of the Board Sören Mellstig.
The Nomination Committee's proposal for Board members:
Sören Mellstig - Chairman of the Board
Christer Fåhraeus - Board Member
Åsa Hedin - Board Member
Roger Johanson - Board Member
Torbjörn Kronander - Board Member
Anna Malm Bernsten - Board Member
Niklas Prager - Board Member
The Nomination Committee believes that the Board's expertise and experience thus
meets the requirements that may arise. The Nomination Committee's other
proposals to the Annual General Meeting, that will be held in Lund on
CellaVision AB at 15:00 on May 5, will be published in the notice of the Annual
General Meeting released to the public on
March 28, 2017.
For more information, please contact:
Christer Fåhraeus, Chairman of the Nomination Committee, CellaVision AB
Tel: +46 (0) 705-60 90 00 | E-mail: cf(at)flatfrog.com
Sören Mellstig, Chairman of the Board, CellaVision AB
Tel: +46 (0) 70- 513 65 81| E-mail: soren(at)mellstig.se
About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The products rationalize manual laboratory work,
and secure and support effective workflows and skills development within and
between hospitals. The company has leading-edge expertise in image analysis,
artificial intelligence and automated microscopy. Sales are via global partners
with support from the mother company in Lund and by the market support
organizations in the US, Canada, China and Japan. In 2015 sales were SEK 239
million and sales continue to increase, with a growth target of at least 15 %
per year over an economic cycle. CellaVision's registered office is in Lund,
Sweden. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more
at www.cellavision.com
Pdf:
http://hugin.info/132164/R/2073709/779536.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CellaVision AB via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 27.01.2017 - 08:20 Uhr
Sprache: Deutsch
News-ID 520344
Anzahl Zeichen: 3384
contact information:
Town:
Lund
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 167 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision AB: Nomination Committee proposes re-election of Chairman and members to the Board of Directors"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
